{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:42:59Z","timestamp":1785321779951,"version":"3.55.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.det.2018.08.001","type":"journal-article","created":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T19:31:04Z","timestamp":1542655864000},"page":"49-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Advances in Inflammatory Granulomatous Skin Diseases"],"prefix":"10.1016","volume":"37","author":[{"given":"Sotonye","family":"Imadojemu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misha","family":"Rosenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.det.2018.08.001_bib1","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1111\/jdv.13760","article-title":"Epidemiology of cutaneous sarcoidosis, 1976-2013: a population-based study from Olmsted County, Minnesota","volume":"3","author":"Ungprasert","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"10 Pt 1","key":"10.1016\/j.det.2018.08.001_bib2","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.det.2018.08.001_bib3","first-page":"55","article-title":"Cell-mediated immune responses in sarcoidosis","volume":"117","author":"Goldstein","year":"1978","journal-title":"Am Rev Respir Dis"},{"issue":"3\u20134","key":"10.1016\/j.det.2018.08.001_bib4","first-page":"197","article-title":"Sarcoidosis and autoimmunity: from genetic background to environmental factors","volume":"18","author":"Bindoli","year":"2016","journal-title":"Isr Med Assoc J"},{"issue":"5","key":"10.1016\/j.det.2018.08.001_bib5","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s10875-012-9700-5","article-title":"Dual analysis for mycobacteria and propionibacteria in sarcoidosis BAL","volume":"32","author":"Oswald-Richter","year":"2012","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.det.2018.08.001_bib6","doi-asserted-by":"crossref","first-page":"935289","DOI":"10.1155\/2013\/935289","article-title":"Etiologic aspect of sarcoidosis as an allergic endogenous infection caused by Propionibacterium acnes","volume":"2013","author":"Eishi","year":"2013","journal-title":"Biomed Res Int"},{"issue":"1","key":"10.1016\/j.det.2018.08.001_bib7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.tube.2005.09.004","article-title":"Serum anti-mycobacterial heat shock proteins antibodies in sarcoidosis and tuberculosis","volume":"86","author":"Dubaniewicz","year":"2006","journal-title":"Tuberculosis"},{"issue":"21","key":"10.1016\/j.det.2018.08.001_bib8","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.det.2018.08.001_bib9","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1378\/chest.06-2114","article-title":"World Trade Center \"sarcoid-like\" granulomatous pulmonary disease in New York City Fire Department rescue workers","volume":"131","author":"Izbicki","year":"2007","journal-title":"Chest"},{"issue":"9679","key":"10.1016\/j.det.2018.08.001_bib10","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(09)61057-6","article-title":"Silica in oral drugs as a possible sarcoidosis-inducing antigen","volume":"373","author":"Sola","year":"2009","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.det.2018.08.001_bib11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrrheum.2011.93","article-title":"Sarcoidosis--scientific progress and clinical challenges","volume":"7","author":"Chen","year":"2011","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.det.2018.08.001_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/MOH.0000000000000301","article-title":"Mechanism of granuloma formation in sarcoidosis","volume":"24","author":"Sakthivel","year":"2017","journal-title":"Curr Opin Hematol"},{"issue":"1","key":"10.1016\/j.det.2018.08.001_bib13","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1378\/chest.106.1.156","article-title":"Significance of interleukin 6 in patients with sarcoidosis","volume":"106","author":"Sahashi","year":"1994","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.det.2018.08.001_bib14","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2230.2011.04128.x","article-title":"Specific cutaneous lesions in patients with systemic sarcoidosis: relationship to severity and chronicity of disease","volume":"36","author":"Marcoval","year":"2011","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"10.1016\/j.det.2018.08.001_bib15","first-page":"113","article-title":"Pulmonary sarcoidosis in the Nordic countries 1950-1982. II. Course and prognosis","volume":"7","author":"Milman","year":"1990","journal-title":"Sarcoidosis"},{"issue":"12","key":"10.1016\/j.det.2018.08.001_bib16","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1600-0560.2006.00563.x","article-title":"Clinical spectrum and histological analysis of 32 cases of specific cutaneous sarcoidosis","volume":"33","author":"Mangas","year":"2006","journal-title":"J\u00a0Cutan Pathol"},{"issue":"3","key":"10.1016\/j.det.2018.08.001_bib17","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jdcr.2017.02.015","article-title":"Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma","volume":"3","author":"Birnbaum","year":"2017","journal-title":"JAAD Case Rep"},{"issue":"1","key":"10.1016\/j.det.2018.08.001_bib18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40425-018-0323-0","article-title":"Granulomatous\/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients","volume":"6","author":"Tetzlaff","year":"2018","journal-title":"J\u00a0Immunother Cancer"},{"issue":"3","key":"10.1016\/j.det.2018.08.001_bib19","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/CMR.0000000000000437","article-title":"Sarcoid-like reactions in patients receiving modern melanoma treatment","volume":"28","author":"Dimitriou","year":"2018","journal-title":"Melanoma Res"},{"issue":"4","key":"10.1016\/j.det.2018.08.001_bib20","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jdcr.2016.06.004","article-title":"Pembrolizumab-associated sarcoidosis","volume":"2","author":"Cotliar","year":"2016","journal-title":"JAAD Case Rep"},{"issue":"8","key":"10.1016\/j.det.2018.08.001_bib21","first-page":"307","article-title":"Sarcoidosis following anti-PD-1 and anti-CTLA-4 therapy for metastatic melanoma","volume":"40","author":"Reddy","year":"2017","journal-title":"J\u00a0Immunother"},{"key":"10.1016\/j.det.2018.08.001_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2018.03.056","article-title":"Drug-induced sarcoidosis-like reactions","author":"Chopra","year":"2018","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.det.2018.08.001_bib23","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.autrev.2010.11.001","article-title":"Excess of autoimmune and chronic inflammatory disorders in patients with lymphoma compared with all cancer patients: a cancer registry-based analysis in the south of the Netherlands","volume":"10","author":"van de Schans","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.det.2018.08.001_bib24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000455877","article-title":"Characteristics of sarcoidosis in patients with previous malignancy: causality or coincidence?","volume":"93","author":"Arish","year":"2017","journal-title":"Respiration"},{"issue":"3","key":"10.1016\/j.det.2018.08.001_bib25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/bjc.1974.64","article-title":"The incidence of malignant tumours in patients with respiratory sarcoidosis","volume":"29","author":"Brincker","year":"1974","journal-title":"Br J Cancer"},{"issue":"12","key":"10.1016\/j.det.2018.08.001_bib26","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1016\/j.rmed.2007.07.012","article-title":"The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK","volume":"101","author":"Le Jeune","year":"2007","journal-title":"Respir Med"},{"issue":"10","key":"10.1016\/j.det.2018.08.001_bib27","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1136\/thx.52.10.892","article-title":"Risk of malignant neoplasms in patients with pulmonary sarcoidosis","volume":"52","author":"Seersholm","year":"1997","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.det.2018.08.001_bib28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/acr.22941","article-title":"Risk of malignancy among patients with sarcoidosis: a population-based cohort study","volume":"69","author":"Ungprasert","year":"2017","journal-title":"Arthritis Care Res"},{"issue":"6","key":"10.1016\/j.det.2018.08.001_bib29","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/ced.13558","article-title":"Cutaneous sarcoidosis: a new subset in the spectrum of paraneoplastic dermatoses","volume":"43","author":"El-Khalawany","year":"2018","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"10.1016\/j.det.2018.08.001_bib30","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/annonc\/mdw125","article-title":"Pulmonary sarcoidosis induced by the anti-PD1 monoclonal antibody pembrolizumab","volume":"27","author":"Cousin","year":"2016","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.det.2018.08.001_bib31","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1183\/09031936.00043010","article-title":"The relationship between sarcoidosis and lymphoma","volume":"36","author":"Papanikolaou","year":"2010","journal-title":"Eur Respir J"},{"issue":"21","key":"10.1016\/j.det.2018.08.001_bib32","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1097\/MD.0000000000000121","article-title":"Sarcoidosis occurring after lymphoma: report of 14 patients and review of the literature","volume":"93","author":"London","year":"2014","journal-title":"Medicine"},{"issue":"13","key":"10.1016\/j.det.2018.08.001_bib33","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2217\/imt-2017-0128","article-title":"Sarcoidosis, malignancy and immune checkpoint blockade","volume":"9","author":"Gaughan","year":"2017","journal-title":"Immunotherapy"},{"issue":"1","key":"10.1016\/j.det.2018.08.001_bib34","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1165\/rcmb.2016-0037OC","article-title":"Programmed death-1 inhibition of phosphatidylinositol 3-kinase\/AKT\/mechanistic target of rapamycin signaling impairs sarcoidosis CD4(+) T cell proliferation","volume":"56","author":"Celada","year":"2017","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"10.1016\/j.det.2018.08.001_bib35","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/PAS.0000000000000590","article-title":"Expression of programmed cell death 1 ligands (PD-L1 and PD-L2) in histiocytic and dendritic cell disorders","volume":"40","author":"Xu","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.det.2018.08.001_bib36","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1164\/rccm.201401-0188OC","article-title":"Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity","volume":"190","author":"Braun","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.det.2018.08.001_bib37","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1001\/archderm.1966.01600210008002","article-title":"Necrobiosis lipoidica diabeticorum. A clinical and pathological investigation of 171 cases","volume":"93","author":"Muller","year":"1966","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.det.2018.08.001_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archderm.1966.01600250007001","article-title":"Necrobiosis lipoidica diabeticorum histopathologic study of 98 cases","volume":"94","author":"Muller","year":"1966","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.det.2018.08.001_bib39","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1684\/ejd.2015.2636","article-title":"Updated results of 100 patients on clinical features and therapeutic options in necrobiosis lipoidica in a retrospective multicentre study","volume":"25","author":"Erfurt-Berge","year":"2015","journal-title":"Eur J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2018.08.001_bib40","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1365-2133.1999.02663.x","article-title":"Necrobiosis lipoidica: only a minority of patients have\u00a0diabetes mellitus","volume":"140","author":"O'Toole","year":"1999","journal-title":"Br J Dermatol"},{"issue":"5 Pt 1","key":"10.1016\/j.det.2018.08.001_bib41","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0190-9622(08)80961-9","article-title":"Necrobiosis lipoidica","volume":"25","author":"Lowitt","year":"1991","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2018.08.001_bib42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.sder.2007.02.004","article-title":"Necrobiosis lipoidica","volume":"26","author":"Peyri","year":"2007","journal-title":"Semin Cutan Med Surg"},{"issue":"1","key":"10.1016\/j.det.2018.08.001_bib43","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/dme.13138","article-title":"Risk factors for necrobiosis lipoidica in Type 1 diabetes mellitus","volume":"34","author":"Hammer","year":"2017","journal-title":"Diabet Med"},{"key":"10.1016\/j.det.2018.08.001_bib44","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/archderm.1960.01580050133020","article-title":"The pathogenesis of necrobiosis lipoidica. Necrobiosis lipoidica, a form fruste of diabetes mellitus","volume":"82","author":"Engel","year":"1960","journal-title":"Arch Dermatol"},{"issue":"9","key":"10.1016\/j.det.2018.08.001_bib45","first-page":"581","article-title":"Cutaneous microcirculation in pretibial necrobiosis lipoidica. Comparative laser Doppler flowmetry and oxygen partial pressure determinations in patients and healthy probands","volume":"44","author":"Boateng","year":"1993","journal-title":"Hautarzt"},{"issue":"4","key":"10.1016\/j.det.2018.08.001_bib46","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-4632.2008.03549.x","article-title":"Skin blood flow in necrobiosis lipoidica diabeticorum","volume":"47","author":"Ngo","year":"2008","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2018.08.001_bib47","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/1523-1747.ep12525395","article-title":"Necrobiosis lipoidica: ultrastructural and biochemical demonstration of a collagen defect","volume":"88","author":"Oikarinen","year":"1987","journal-title":"J\u00a0Invest Dermatol"},{"issue":"6","key":"10.1016\/j.det.2018.08.001_bib48","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1034\/j.1600-0560.2001.028006287.x","article-title":"Expression of the human erythrocyte glucose transporter Glut-1 in areas of sclerotic collagen in necrobiosis lipoidica","volume":"28","author":"Holland","year":"2001","journal-title":"J\u00a0Cutan Pathol"},{"issue":"1","key":"10.1016\/j.det.2018.08.001_bib49","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2133.1975.tb06481.x","article-title":"Granuloma annulare and necrobiosis lipoidica treated by jet injector","volume":"93","author":"Sparrow","year":"1975","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2018.08.001_bib50","unstructured":"Wanat KRM. Necrobiosis lipoidica. In: Callen J, editor. UpToDate. Waltham (MA): UpToDate. Accessed May 29, 2018."},{"issue":"4","key":"10.1016\/j.det.2018.08.001_bib51","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.metabol.2015.12.014","article-title":"Anti-TNFalpha treatment for recalcitrant ulcerative necrobiosis lipoidica diabeticorum: a case report and review of the literature","volume":"65","author":"Basoulis","year":"2016","journal-title":"Metabolism"},{"issue":"5\u20136","key":"10.1016\/j.det.2018.08.001_bib52","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/1759720X18776224","article-title":"The role of the JAK\/STAT signal pathway in rheumatoid arthritis","volume":"10","author":"Malemud","year":"2018","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"4","key":"10.1016\/j.det.2018.08.001_bib53","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaad.2016.12.005","article-title":"JAK inhibitors in dermatology: the promise of a new drug class","volume":"76","author":"Damsky","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1\u20134","key":"10.1016\/j.det.2018.08.001_bib54","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/10799899909036638","article-title":"The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus","volume":"19","author":"Heim","year":"1999","journal-title":"J\u00a0Recept Signal Transduct Res"},{"key":"10.1016\/j.det.2018.08.001_bib55","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/OARRR.S6266","article-title":"Recent advances in neutralizing the IL-6 pathway in arthritis","volume":"1","author":"Malemud","year":"2009","journal-title":"Open access Rheumatol"},{"key":"10.1016\/j.det.2018.08.001_bib56","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4172\/2161-1149.1000113","article-title":"Monosodium urate and tumor necrosis factor-alpha increase apoptosis in human chondrocyte cultures","volume":"2","author":"Malemud","year":"2012","journal-title":"Rheumatology (Sunnyvale)"},{"issue":"6","key":"10.1016\/j.det.2018.08.001_bib57","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/jamadermatol.2018.0756","article-title":"Improvement in ulcerative necrobiosis lipoidica after janus kinase-inhibitor therapy for polycythemia vera","volume":"154","author":"Lee","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.det.2018.08.001_bib58","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0190-9622(80)80181-2","article-title":"Granuloma annulare","volume":"3","author":"Muhlbauer","year":"1980","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2018.08.001_bib59","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jaad.2015.03.054","article-title":"Granuloma annulare: clinical and histologic variants, epidemiology, and genetics","volume":"75","author":"Piette","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2018.08.001_bib60","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5021\/ad.2009.21.2.113","article-title":"Clinical and pathological features of generalized granuloma annulare with their correlation: a retrospective multicenter study in Korea","volume":"21","author":"Yun","year":"2009","journal-title":"Ann Dermatol"},{"issue":"3","key":"10.1016\/j.det.2018.08.001_bib61","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.det.2015.03.001","article-title":"Granuloma annulare","volume":"33","author":"Keimig","year":"2015","journal-title":"Dermatol Clin"},{"issue":"6","key":"10.1016\/j.det.2018.08.001_bib62","doi-asserted-by":"crossref","first-page":"18572","DOI":"10.5070\/D3196018572","article-title":"Localized interstitial granuloma annulare induced by subcutaneous injections for desensitization","volume":"19","author":"Spring","year":"2013","journal-title":"Dermatol Online J"},{"issue":"2","key":"10.1016\/j.det.2018.08.001_bib63","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/ijd.12189","article-title":"Granuloma annulare as a possible new adverse effect of topiramate","volume":"53","author":"Cassone","year":"2014","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2018.08.001_bib64","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/1346-8138.12293","article-title":"Generalized granuloma annulare after bacillus Calmette-Guerin vaccination, clinically resembling papular tuberculid","volume":"41","author":"Yoon","year":"2014","journal-title":"J\u00a0Dermatol"},{"issue":"5","key":"10.1016\/j.det.2018.08.001_bib65","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1468-3083.2004.00989.x","article-title":"Two case reports of cutaneous adverse reactions following hepatitis B vaccine: lichen planus and granuloma annulare","volume":"18","author":"Criado","year":"2004","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.det.2018.08.001_bib66","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1111\/j.1365-2230.2008.03183.x","article-title":"Generalized granuloma annulare in a photosensitive distribution resolving with scarring and milia formation","volume":"34","author":"Gass","year":"2009","journal-title":"Clin Exp Dermatol"},{"issue":"8","key":"10.1016\/j.det.2018.08.001_bib67","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s004030000150","article-title":"Expression of IFNgamma, coexpression of TNFalpha and matrix metalloproteinases and apoptosis of T lymphocytes and macrophages in granuloma annulare","volume":"292","author":"Fayyazi","year":"2000","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"10.1016\/j.det.2018.08.001_bib68","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1046\/j.1523-1747.2002.01783.x","article-title":"T-cell receptor repertoire and cytokine pattern in granuloma annulare: defining a particular type of cutaneous granulomatous inflammation","volume":"118","author":"Mempel","year":"2002","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2018.08.001_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2018.05.035","article-title":"Characterization of dermatitis after PD-1\/PD-L1 inhibitor therapy and association with multiple oncologic outcomes: a retrospective case-control study","author":"Min Lee","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2018.08.001_bib70","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1111\/jdv.14617","article-title":"Granuloma annulare associated with immune checkpoint inhibitors","volume":"32","author":"Wu","year":"2018","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.det.2018.08.001_bib71","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.annder.2017.11.005","article-title":"Two cases of granuloma annulare under anti-PD1 therapy","volume":"145","author":"Charollais","year":"2018","journal-title":"Ann Dermatol Venereol"},{"issue":"9","key":"10.1016\/j.det.2018.08.001_bib72","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1046\/j.1365-4362.2001.01248-2.x","article-title":"Multiple lesions of granuloma annulare following BCG vaccination: case report and review of the literature","volume":"40","author":"Kakurai","year":"2001","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2018.08.001_bib73","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1684\/ejd.2011.1512","article-title":"Generalized granuloma annulare following BCG vaccination, mimicking papular tuberculid","volume":"21","author":"Nagase","year":"2011","journal-title":"Eur J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2018.08.001_bib74","first-page":"435","article-title":"Generalized granuloma annulare and hepatitis B vaccination","volume":"8","author":"Wolf","year":"1998","journal-title":"Eur J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2018.08.001_bib75","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/CCO.0000000000000263","article-title":"Predictive biomarkers for programmed death-1\/programmed death ligand immune checkpoint inhibitors in nonsmall cell lung cancer","volume":"28","author":"Remon","year":"2016","journal-title":"Curr Opin Oncol"},{"issue":"8","key":"10.1016\/j.det.2018.08.001_bib76","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1158\/2326-6066.CIR-16-0022","article-title":"Interferon-gamma production by peripheral lymphocytes predicts survival of tumor-bearing mice receiving dual PD-1\/CTLA-4 blockade","volume":"4","author":"McNamara","year":"2016","journal-title":"Cancer Immunol Res"},{"issue":"22","key":"10.1016\/j.det.2018.08.001_bib77","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.1158\/1078-0432.CCR-15-2839","article-title":"Immunomodulatory activity of nivolumab in metastatic renal cell carcinoma","volume":"22","author":"Choueiri","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.det.2018.08.001_bib78","first-page":"426479","article-title":"Literature-based discovery of IFN-gamma and vaccine-mediated gene interaction networks","volume":"2010","author":"Ozgur","year":"2010","journal-title":"J\u00a0Biomed Biotechnol"},{"issue":"4","key":"10.1016\/j.det.2018.08.001_bib79","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jaad.2016.11.044","article-title":"Antimalarial therapy for granuloma annulare: results of a retrospective analysis","volume":"76","author":"Grewal","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2018.08.001_bib80","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jaad.2007.09.019","article-title":"Palisaded neutrophilic and granulomatous dermatitis associated with limited systemic sclerosis","volume":"58","author":"Hantash","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2018.08.001_bib81","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.det.2015.03.005","article-title":"Reactive granulomatous dermatitis: a review of palisaded neutrophilic and granulomatous dermatitis, interstitial granulomatous dermatitis, interstitial granulomatous drug reaction, and a proposed reclassification","volume":"33","author":"Rosenbach","year":"2015","journal-title":"Dermatol Clin"},{"issue":"4","key":"10.1016\/j.det.2018.08.001_bib82","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/03009740510015195","article-title":"Palisaded neutrophilic granulomatous dermatitis presenting as an unusual skin manifestation in a patient with Behcet's disease","volume":"34","author":"Kim","year":"2005","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"10.1016\/j.det.2018.08.001_bib83","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00005792-198305000-00002","article-title":"The cutaneous extravascular necrotizing granuloma (Churg-Strauss granuloma) and systemic disease: a review of 27 cases","volume":"62","author":"Finan","year":"1983","journal-title":"Medicine"},{"issue":"5","key":"10.1016\/j.det.2018.08.001_bib84","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-2230.2005.01802.x","article-title":"Palisaded neutrophilic and granulomatous dermatitis","volume":"30","author":"Al-Daraji","year":"2005","journal-title":"Clin Exp Dermatol"},{"issue":"10","key":"10.1016\/j.det.2018.08.001_bib85","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1600-0560.2009.01466.x","article-title":"Palisaded neutrophilic granulomatous dermatitis with leukocytoclastic vasculitis in a patient without any underlying systemic disease detected to date","volume":"37","author":"Misago","year":"2010","journal-title":"J\u00a0Cutan Pathol"},{"issue":"2","key":"10.1016\/j.det.2018.08.001_bib86","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1067\/mjd.2002.124620","article-title":"Palisaded neutrophilic granulomatous dermatitis in rheumatoid arthritis","volume":"47","author":"Sangueza","year":"2002","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2018.08.001_bib87","first-page":"365","article-title":"Palisaded neutrophilic and granulomatous dermatitis in association with sarcoidosis","volume":"38","author":"Mahmoodi","year":"2011","journal-title":"J\u00a0Cutan Pathol"},{"issue":"3","key":"10.1016\/j.det.2018.08.001_bib88","first-page":"234","article-title":"Early lesion of palisaded neutrophilic granulomatous dermatitis in ulcerative colitis","volume":"17","author":"Asahina","year":"2007","journal-title":"Eur J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2018.08.001_bib89","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1468-3083.2006.01752.x","article-title":"Erythema elevatum diutinum in the spectrum of palisaded neutrophilic granulomatous dermatitis: description of a case with rheumatoid arthritis","volume":"21","author":"Muscardin","year":"2007","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"Suppl 3","key":"10.1016\/j.det.2018.08.001_bib90","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-4632.2007.03509.x","article-title":"Cutaneous granulomas in rheumatoid arthritis","volume":"46","author":"Collaris","year":"2007","journal-title":"Int J Dermatol"},{"issue":"10","key":"10.1016\/j.det.2018.08.001_bib91","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/archderm.1994.01690100062010","article-title":"The histopathologic spectrum of palisaded neutrophilic and granulomatous dermatitis in patients with collagen vascular disease","volume":"130","author":"Chu","year":"1994","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.det.2018.08.001_bib92","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1111\/pde.12144","article-title":"A\u00a0child with interstitial granulomatous dermatitis and juvenile idiopathic arthritis","volume":"30","author":"Moon","year":"2013","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"10.1016\/j.det.2018.08.001_bib93","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2133.2011.10727.x","article-title":"Interstitial granulomatous dermatitis: a distinct entity with characteristic histological and clinical pattern","volume":"166","author":"Peroni","year":"2012","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2018.08.001_bib94","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-0560.1998.tb01693.x","article-title":"The interstitial granulomatous drug reaction: a distinctive clinical and pathological entity","volume":"25","author":"Magro","year":"1998","journal-title":"J\u00a0Cutan Pathol"},{"issue":"6","key":"10.1016\/j.det.2018.08.001_bib95","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1067\/mjd.2002.120532","article-title":"Interstitial granulomatous dermatitis with plaques","volume":"46","author":"Tomasini","year":"2002","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2018.08.001_bib96","doi-asserted-by":"crossref","first-page":"134","DOI":"10.7326\/0003-4819-63-1-134","article-title":"Linear subcutaneous bands in rheumatoid arthritis. an unusual form of rheumatoid granuloma","volume":"63","author":"Dykman","year":"1965","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.det.2018.08.001_bib97","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10067-009-1287-8","article-title":"Interstitial granulomatous dermatitis in rheumatoid arthritis responsive to etanercept","volume":"29","author":"Zoli","year":"2010","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.det.2018.08.001_bib98","first-page":"661","article-title":"Interstitial granulomatous dermatitis (Ackerman's Syndrome)","volume":"20","author":"Felcht","year":"2010","journal-title":"Eur J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2018.08.001_bib99","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1365-2230.2008.02774.x","article-title":"Interstitial granulomatous dermatitis: a misdiagnosed cutaneous form of systemic lupus erythematosus?","volume":"33","author":"Blaise","year":"2008","journal-title":"Clin Exp Dermatol"},{"issue":"8","key":"10.1016\/j.det.2018.08.001_bib100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5070\/D33MT6F90R","article-title":"Interstitial granulomatous dermatitis with arthritis","volume":"15","author":"Jabbari","year":"2009","journal-title":"Dermatol Online J"},{"issue":"6","key":"10.1016\/j.det.2018.08.001_bib101","first-page":"1207","article-title":"Interstitial granulomatous dermatitis with arthritis (Ackerman syndrome)","volume":"33","author":"Busquets-Perez","year":"2006","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.det.2018.08.001_bib102","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1346-8138.2010.01015.x","article-title":"Interstitial granulomatous dermatitis? An unusual presentation in the mucosa and periungual skin","volume":"38","author":"Nakamura","year":"2011","journal-title":"J\u00a0Dermatol"},{"issue":"5","key":"10.1016\/j.det.2018.08.001_bib103","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1468-3083.2006.01982.x","article-title":"Interstitial granulomatous dermatitis associated with autoimmune hepatitis","volume":"21","author":"Lee","year":"2007","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.det.2018.08.001_bib104","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/CMR.0000000000000186","article-title":"Granulomatous nephritis and dermatitis in a patient with BRAF V600E mutant metastatic melanoma treated with dabrafenib and trametinib","volume":"25","author":"Jansen","year":"2015","journal-title":"Melanoma Res"},{"issue":"8","key":"10.1016\/j.det.2018.08.001_bib105","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/cup.13267","article-title":"Granulomatous dermatitis associated with ipilimumab therapy (ipilimumab associated granulomatous dermatitis)","volume":"45","author":"Kubicki","year":"2018","journal-title":"J\u00a0Cutan Pathol"},{"issue":"7","key":"10.1016\/j.det.2018.08.001_bib106","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/cup.13150","article-title":"Dermatologic toxicity from immune checkpoint blockade therapy with an interstitial granulomatous pattern","volume":"45","author":"Trinidad","year":"2018","journal-title":"J\u00a0Cutan Pathol"},{"issue":"1","key":"10.1016\/j.det.2018.08.001_bib107","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/cup.13048","article-title":"Chronic granulomatous dermatitis induced by talimogene laherparepvec therapy of melanoma metastases","volume":"45","author":"Everett","year":"2018","journal-title":"J\u00a0Cutan Pathol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863518311057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863518311057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:43:06Z","timestamp":1760006586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863518311057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":107,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0733863518311057"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2018.08.001","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in Inflammatory Granulomatous Skin Diseases","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2018.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}